Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Mann

Showing results (21-30 of 254) with videos related to

Pageof 26
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|June 19, 2004
Does psychiatric comorbidity in alcohol-dependent patients affect treatment outcome?Karl Mann, Thomas Hintz, Martin Jung
Addiction (Abingdon, England)|November 2, 2002
Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholismDerik Hermann, Andreas Heinz, Karl Mann
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 23, 2018
Response to Letter to Editor (Precision medicine in alcohol dependence: evidence of efficacy and initial support for comparative effectiveness)Karl Mann, Corey R Roos, Katie Witkiewitz
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2016
Does Acamprosate Really Produce its Anti-Relapse Effects via Calcium? No Support from the PREDICT Study in Human AlcoholicsKarl Mann, Sabine Hoffmann, Cornelius R Pawlak
Alcoholism, Clinical and Experimental Research|January 28, 2004
The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysisKarl Mann, Philippe Lehert, Marsha Y Morgan
European Addiction Research|September 22, 2017
Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?Karl Mann, Henri-Jean Aubin, Katie Witkiewitz
Addictive Behaviors|November 15, 2012
Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT studyAngelika Glöckner-Rist, Tagrid Lémenager, Karl Mann, et al.
Addiction Biology|August 3, 2016
Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexoneCorey R Roos, Karl Mann, Katie Witkiewitz
Psychiatrische Praxis|October 17, 2008
[Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS)]Helmut Nakovics, Alexander Diehl, Harry Geiselhart, et al.
The American Journal of Drug and Alcohol Abuse|September 30, 2008
Oxcarbazepine in rapid benzodiazepine detoxificationBernhard Croissant, Martin Grosshans, Alexander Diehl, et al.
Pageof 26

Showing results (21-30 of 254) with videos related to

Sort By:
Pageof 26
European Archives of Psychiatry and Clinical Neuroscience|June 19, 2004
Does psychiatric comorbidity in alcohol-dependent patients affect treatment outcome?Karl Mann, Thomas Hintz, Martin Jung
Addiction (Abingdon, England)|November 2, 2002
Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholismDerik Hermann, Andreas Heinz, Karl Mann
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 23, 2018
Response to Letter to Editor (Precision medicine in alcohol dependence: evidence of efficacy and initial support for comparative effectiveness)Karl Mann, Corey R Roos, Katie Witkiewitz
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2016
Does Acamprosate Really Produce its Anti-Relapse Effects via Calcium? No Support from the PREDICT Study in Human AlcoholicsKarl Mann, Sabine Hoffmann, Cornelius R Pawlak
Alcoholism, Clinical and Experimental Research|January 28, 2004
The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysisKarl Mann, Philippe Lehert, Marsha Y Morgan
European Addiction Research|September 22, 2017
Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?Karl Mann, Henri-Jean Aubin, Katie Witkiewitz
Addictive Behaviors|November 15, 2012
Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT studyAngelika Glöckner-Rist, Tagrid Lémenager, Karl Mann, et al.
Addiction Biology|August 3, 2016
Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexoneCorey R Roos, Karl Mann, Katie Witkiewitz
Psychiatrische Praxis|October 17, 2008
[Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS)]Helmut Nakovics, Alexander Diehl, Harry Geiselhart, et al.
The American Journal of Drug and Alcohol Abuse|September 30, 2008
Oxcarbazepine in rapid benzodiazepine detoxificationBernhard Croissant, Martin Grosshans, Alexander Diehl, et al.
Pageof 26